about
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causi...
Read More
4.58
0.04
(0.88%)
716.9K
XNAS Volume
XNAS 04 Sep, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Rezolute Inc is on 15 Sep 2026 for the purpose of Morgan Stanley 24(th) Annual Global Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Neutral
Rezolute Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..